In this report, the United States Insomnia Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Insomnia Therapy in these regions, from 2012 to 2022 (forecast). United States Insomnia Therapy market competition by top manufacturers/players, with Insomnia Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Merck & Co. Inc. Sanofi Pfizer, Inc. Takeda Pharmaceutical Company Ltd. Purdue Pharmaceuticals L.P. Eisai, Co. Ltd. Meda Consumer Healthcare Inc.... Research Beam Model: Research Beam Product ID: 2710229 3800 USD New
United States Insomnia Therapy Market Report 2017
 
 

United States Insomnia Therapy Market Report 2017

  • Category : Medical Devices
  • Published On : November   2017
  • Pages : 106
  • Publisher : QYResearch
 
 
 
In this report, the United States Insomnia Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Insomnia Therapy in these regions, from 2012 to 2022 (forecast).

United States Insomnia Therapy market competition by top manufacturers/players, with Insomnia Therapy sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Merck & Co. Inc.
Sanofi
Pfizer, Inc.
Takeda Pharmaceutical Company Ltd.
Purdue Pharmaceuticals L.P.
Eisai, Co. Ltd.
Meda Consumer Healthcare Inc.
Pernix Therapeutics
Vanda Pharmaceuticals
ECR Pharmaceuticals
Fidia Farmaceutici
Dainippon Sumitomo
Biocodex
Eli Lilly and Company
Ebb Therapeutics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Non-pharmacological Therapy
Pharmacological Therapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Ambulatory Surgical Center
Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Insomnia Therapy Market Report 2017
1 Insomnia Therapy Overview
1.1 Product Overview and Scope of Insomnia Therapy
1.2 Classification of Insomnia Therapy by Product Category
1.2.1 United States Insomnia Therapy Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Insomnia Therapy Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Non-pharmacological Therapy
1.2.4 Pharmacological Therapy
1.3 United States Insomnia Therapy Market by Application/End Users
1.3.1 United States Insomnia Therapy Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Home Care
1.4 United States Insomnia Therapy Market by Region
1.4.1 United States Insomnia Therapy Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Insomnia Therapy Status and Prospect (2012-2022)
1.4.3 Southwest Insomnia Therapy Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Insomnia Therapy Status and Prospect (2012-2022)
1.4.5 New England Insomnia Therapy Status and Prospect (2012-2022)
1.4.6 The South Insomnia Therapy Status and Prospect (2012-2022)
1.4.7 The Midwest Insomnia Therapy Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Insomnia Therapy (2012-2022)
1.5.1 United States Insomnia Therapy Sales and Growth Rate (2012-2022)
1.5.2 United States Insomnia Therapy Revenue and Growth Rate (2012-2022)

2 United States Insomnia Therapy Market Competition by Players/Suppliers
2.1 United States Insomnia Therapy Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Insomnia Therapy Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Insomnia Therapy Average Price by Players/Suppliers (2012-2017)
2.4 United States Insomnia Therapy Market Competitive Situation and Trends
2.4.1 United States Insomnia Therapy Market Concentration Rate
2.4.2 United States Insomnia Therapy Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Insomnia Therapy Manufacturing Base Distribution, Sales Area, Product Type

3 United States Insomnia Therapy Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Insomnia Therapy Sales and Market Share by Region (2012-2017)
3.2 United States Insomnia Therapy Revenue and Market Share by Region (2012-2017)
3.3 United States Insomnia Therapy Price by Region (2012-2017)

4 United States Insomnia Therapy Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Insomnia Therapy Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Insomnia Therapy Revenue and Market Share by Type (2012-2017)
4.3 United States Insomnia Therapy Price by Type (2012-2017)
4.4 United States Insomnia Therapy Sales Growth Rate by Type (2012-2017)

5 United States Insomnia Therapy Sales (Volume) by Application (2012-2017)
5.1 United States Insomnia Therapy Sales and Market Share by Application (2012-2017)
5.2 United States Insomnia Therapy Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Insomnia Therapy Players/Suppliers Profiles and Sales Data
6.1 Merck & Co. Inc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Insomnia Therapy Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck & Co. Inc. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sanofi
6.2.2 Insomnia Therapy Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Pfizer, Inc.
6.3.2 Insomnia Therapy Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer, Inc. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Takeda Pharmaceutical Company Ltd.
6.4.2 Insomnia Therapy Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Purdue Pharmaceuticals L.P.
6.5.2 Insomnia Therapy Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Eisai, Co. Ltd.
6.6.2 Insomnia Therapy Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Eisai, Co. Ltd. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Meda Consumer Healthcare Inc.
6.7.2 Insomnia Therapy Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Meda Consumer Healthcare Inc. Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Pernix Therapeutics
6.8.2 Insomnia Therapy Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Pernix Therapeutics Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Vanda Pharmaceuticals
6.9.2 Insomnia Therapy Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Vanda Pharmaceuticals Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 ECR Pharmaceuticals
6.10.2 Insomnia Therapy Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 ECR Pharmaceuticals Insomnia Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Fidia Farmaceutici
6.12 Dainippon Sumitomo
6.13 Biocodex
6.14 Eli Lilly and Company
6.15 Ebb Therapeutics

7 Insomnia Therapy Manufacturing Cost Analysis
7.1 Insomnia Therapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insomnia Therapy

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Insomnia Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insomnia Therapy Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Insomnia Therapy Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Insomnia Therapy Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Insomnia Therapy Sales Volume Forecast by Type (2017-2022)
11.3 United States Insomnia Therapy Sales Volume Forecast by Application (2017-2022)
11.4 United States Insomnia Therapy Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Insomnia Therapy
Figure United States Insomnia Therapy Market Size (K Units) by Type (2012-2022)
Figure United States Insomnia Therapy Sales Volume Market Share by Type (Product Category) in 2016
Figure Non-pharmacological Therapy Product Picture
Figure Pharmacological Therapy Product Picture
Figure United States Insomnia Therapy Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Insomnia Therapy by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Ambulatory Surgical Center Examples
Table Key Downstream Customer in Ambulatory Surgical Center
Figure Home Care Examples
Table Key Downstream Customer in Home Care
Figure United States Insomnia Therapy Market Size (Million USD) by Region (2012-2022)
Figure The West Insomnia Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Insomnia Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Insomnia Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Insomnia Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Insomnia Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Insomnia Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Insomnia Therapy Sales (K Units) and Growth Rate (2012-2022)
Figure United States Insomnia Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Insomnia Therapy Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Insomnia Therapy Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Insomnia Therapy Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Insomnia Therapy Sales Share by Players/Suppliers
Figure 2017 United States Insomnia Therapy Sales Share by Players/Suppliers
Figure United States Insomnia Therapy Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Insomnia Therapy Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Insomnia Therapy Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Insomnia Therapy Revenue Share by Players/Suppliers
Figure 2017 United States Insomnia Therapy Revenue Share by Players/Suppliers
Table United States Market Insomnia Therapy Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Insomnia Therapy Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Insomnia Therapy Market Share of Top 3 Players/Suppliers
Figure United States Insomnia Therapy Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Insomnia Therapy Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Insomnia Therapy Product Category
Table United States Insomnia Therapy Sales (K Units) by Region (2012-2017)
Table United States Insomnia Therapy Sales Share by Region (2012-2017)
Figure United States Insomnia Therapy Sales Share by Region (2012-2017)
Figure United States Insomnia Therapy Sales Market Share by Region in 2016
Table United States Insomnia Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Insomnia Therapy Revenue Share by Region (2012-2017)
Figure United States Insomnia Therapy Revenue Market Share by Region (2012-2017)
Figure United States Insomnia Therapy Revenue Market Share by Region in 2016
Table United States Insomnia Therapy Price (USD/Unit) by Region (2012-2017)
Table United States Insomnia Therapy Sales (K Units) by Type (2012-2017)
Table United States Insomnia Therapy Sales Share by Type (2012-2017)
Figure United States Insomnia Therapy Sales Share by Type (2012-2017)
Figure United States Insomnia Therapy Sales Market Share by Type in 2016
Table United States Insomnia Therapy Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Insomnia Therapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Insomnia Therapy by Type (2012-2017)
Figure Revenue Market Share of Insomnia Therapy by Type in 2016
Table United States Insomnia Therapy Price (USD/Unit) by Types (2012-2017)
Figure United States Insomnia Therapy Sales Growth Rate by Type (2012-2017)
Table United States Insomnia Therapy Sales (K Units) by Application (2012-2017)
Table United States Insomnia Therapy Sales Market Share by Application (2012-2017)
Figure United States Insomnia Therapy Sales Market Share by Application (2012-2017)
Figure United States Insomnia Therapy Sales Market Share by Application in 2016
Table United States Insomnia Therapy Sales Growth Rate by Application (2012-2017)
Figure United States Insomnia Therapy Sales Growth Rate by Application (2012-2017)
Table Merck & Co. Inc. Basic Information List
Table Merck & Co. Inc. Insomnia Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Inc. Insomnia Therapy Sales Growth Rate (2012-2017)
Figure Merck & Co. Inc. Insomnia Therapy Sales Market Share in United States (2012-2017)
Figure Merck & Co. Inc. Insomnia Therapy Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Insomnia Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Insomnia Therapy Sales Growth Rate (2012-2017)
Figure Sanofi Insomnia Therapy Sales Market Share in United States (2012-2017)
Figure Sanofi Insomnia Therapy Revenue Market Share in United States (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Insomnia Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Insomnia Therapy Sales Growth Rate (2012-2017)
Figure Pfizer, Inc. Insomnia Therapy Sales Market Share in United States (2012-2017)
Figure Pfizer, Inc. Insomnia Therapy Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceutical Company Ltd. Basic Information List
Table Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue Market Share in United States (2012-2017)
Table Purdue Pharmaceuticals L.P. Basic Information List
Table Purdue Pharmaceuticals L.P. Insomnia Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Purdue Pharmaceuticals L.P. Insomnia Therapy Sales Growth Rate (2012-2017)
Figure Purdue Pharmaceuticals L.P. Insomnia Therapy Sales Market Share in United States (2012-2017)
Figure Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue Market Share in United States (2012-2017)
Table Eisai, Co. Ltd. Basic Information List
Table Eisai, Co. Ltd. Insomnia Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eisai, Co. Ltd. Insomnia Therapy Sales Growth Rate (2012-2017)
Figure Eisai, Co. Ltd. Insomnia Therapy Sales Market Share in United States (2012-2017)
Figure Eisai, Co. Ltd. Insomnia Therapy Revenue Market Share in United States (2012-2017)
Table Meda Consumer Healthcare Inc. Basic Information List
Table Meda Consumer Healthcare Inc. Insomnia Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Meda Consumer Healthcare Inc. Insomnia Therapy Sales Growth Rate (2012-2017)
Figure Meda Consumer Healthcare Inc. Insomnia Therapy Sales Market Share in United States (2012-2017)
Figure Meda Consumer Healthcare Inc. Insomnia Therapy Revenue Market Share in United States (2012-2017)
Table Pernix Therapeutics Basic Information List
Table Pernix Therapeutics Insomnia Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pernix Therapeutics Insomnia Therapy Sales Growth Rate (2012-2017)
Figure Pernix Therapeutics Insomnia Therapy Sales Market Share in United States (2012-2017)
Figure Pernix Therapeutics Insomnia Therapy Revenue Market Share in United States (2012-2017)
Table Vanda Pharmaceuticals Basic Information List
Table Vanda Pharmaceuticals Insomnia Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vanda Pharmaceuticals Insomnia Therapy Sales Growth Rate (2012-2017)
Figure Vanda Pharmaceuticals Insomnia Therapy Sales Market Share in United States (2012-2017)
Figure Vanda Pharmaceuticals Insomnia Therapy Revenue Market Share in United States (2012-2017)
Table ECR Pharmaceuticals Basic Information List
Table ECR Pharmaceuticals Insomnia Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ECR Pharmaceuticals Insomnia Therapy Sales Growth Rate (2012-2017)
Figure ECR Pharmaceuticals Insomnia Therapy Sales Market Share in United States (2012-2017)
Figure ECR Pharmaceuticals Insomnia Therapy Revenue Market Share in United States (2012-2017)
Table Fidia Farmaceutici Basic Information List
Table Dainippon Sumitomo Basic Information List
Table Biocodex Basic Information List
Table Eli Lilly and Company Basic Information List
Table Ebb Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insomnia Therapy
Figure Manufacturing Process Analysis of Insomnia Therapy
Figure Insomnia Therapy Industrial Chain Analysis
Table Raw Materials Sources of Insomnia Therapy Major Players/Suppliers in 2016
Table Major Buyers of Insomnia Therapy
Table Distributors/Traders List
Figure United States Insomnia Therapy Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Insomnia Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Insomnia Therapy Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Insomnia Therapy Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Insomnia Therapy Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Insomnia Therapy Sales Volume (K Units) Forecast by Type in 2022
Table United States Insomnia Therapy Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Insomnia Therapy Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Insomnia Therapy Sales Volume (K Units) Forecast by Application in 2022
Table United States Insomnia Therapy Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Insomnia Therapy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Insomnia Therapy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Insomnia Therapy Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT